These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6888190)

  • 21. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P
    Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated treatment with imipramine decreased the number of [3H]piflutixol binding sites in the rat striatum.
    Klimek V; Nielsen M; Maj J
    Eur J Pharmacol; 1985 Feb; 109(1):131-2. PubMed ID: 2859994
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.
    Jarvie KR; Booth G; Brown EM; Niznik HB
    Mol Pharmacol; 1989 Oct; 36(4):566-74. PubMed ID: 2682204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone response to dopamine in cattle.
    Blum JW; Kunz P; Fischer JA; Binswanger U; Lichtensteiger W; Da Prada M
    Am J Physiol; 1980 Oct; 239(4):E255-E264. PubMed ID: 7425119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D-1 and D-2 receptors in Huntington's disease.
    Cross A; Rossor M
    Eur J Pharmacol; 1983 Mar; 88(2-3):223-9. PubMed ID: 6221936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine does not affect parathyroid function in man.
    Bansal S; Woolf PD; Fischer JA; Caro JF
    J Clin Endocrinol Metab; 1982 Mar; 54(3):651-2. PubMed ID: 7056847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flupentixol and dopamine receptor selectivity.
    Hyttel J
    Psychopharmacology (Berl); 1981; 75(2):217. PubMed ID: 6798610
    [No Abstract]   [Full Text] [Related]  

  • 33. Irreversible blockade of striatal dopamine receptors in vivo by a derivative of alpha-flupenthixol.
    Schuster DI; Holden WL; Narula AP; Murphy RB
    Eur J Pharmacol; 1982 Feb; 77(4):313-6. PubMed ID: 7060641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assay of dopamine receptors with [alpha-3H]flupenthixol.
    Huff RM; Molinoff PB
    J Pharmacol Exp Ther; 1985 Jan; 232(1):57-61. PubMed ID: 3965700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor subtype imbalance in schizophrenia.
    Hess EJ; Bracha HS; Kleinman JE; Creese I
    Life Sci; 1987 Apr; 40(15):1487-97. PubMed ID: 2951573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
    Lewin E; Almaden Y; Rodriguez M; Olgaard K
    Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors.
    Murugaiah K; Mann S; Theodorou AE; Jenner P; Marsden CD
    Life Sci; 1982 Jul; 31(2):181-8. PubMed ID: 6889662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of 3H-cis-flupenthixol binding to calf brain membranes.
    Cross AJ; Owen F
    Eur J Pharmacol; 1980 Aug; 65(4):341-7. PubMed ID: 7408943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.